The production of PGE2 and PGF2a in the endometrium, which is increased prior to the implantation of mouse and rabbit blastocysts, has been demonstrated to be markedly suppressed after implantation (Ishihara 1986b , Kinoshita 1986 . Although the actual role of PGs generated significantly in the secretory phase of the human endometrium remains uncertain, the synthesis of PGs in decidua in early pregnancy is as clearly inhibited as in mouse and rabbit (Ishihara 1986a) , but the regulatory mechanism of PG production both in endometrium and decidua has been unknown.
Therefore, in an attempt to elucidate the suppression mechanism of PG production in human decidua, studies were undertaken on PG synthetase activities of secretory endometrium and decidua, and on the inhibitory effect of 105,000 g supernatant of both tissues on PG production. The inhibitory effect of 105,000 g supernatant of decidual and endometrial cells on PG synthesis was examined using sheep seminal vesicle microsome as an enzyme source of PG synthetase. The inhibition of PG synthetase activity by various amounts of the decidual supernatant was measured following the incubation of the seminal vesicle microsome with the supernatant for 10 minutes. The inhibition by the decidual supernatant was demonstrated in a dose dependent manner (Fig. 3) . As is clear from Fig. 4 , however, the inhibitory effect of the endometrial supernatant was not so remarkable, being 30% at most, and was not linear.
Subsequently, the types of inhibition were determined graphically with the Dixon plot (Fig. 5 ). As this plot shows, a competitive inhibition is indicated, although the Ki value for the inhibitor in the decidual supernatant was not estimated because of the inpurity of the substrate. On the other hand, the type of inhibition of endometrial supernatant was not assessed because of the parallel straight lines obtained at two different concentrations of the substrate (Fig. 6) . Fig. 7 . Binding of arachidonic acid with albumin, endometrial supernatant and decidual supernatant. By using the dextran coated charcoal method, binding between arachidonic acid and decidual supernatant was approximately 2% at the highest concentration in this study, which was negligible in comparison with total added substrate. Serum albumin could bind much more arachidonic acid. perties of the inhibitor were tested as follows.
The inhibitory activity was reduced completely by heat treating the inhibitor at decidual and endometrial supernatant and albumin with the substrate, arachidonic acid was then studied by the separation method employing dextran-coated charcoal after incubation.
The decidual supernatant was found to bind approximately 2% of the arachidonic acid added to the incubation mixture at the highest inhibitor concentration, whereas the endometrial supernatant and albumin were found to bind fairly large amounts of substrate (Fig. 7) .
Discussion
In mouse and rabbit, the production of PGs in the endometrium after implantation is markedly suppressed. Furthermore, the site of implantation in the endometrium decreased PG synthesis, whereas the capacity for PG synthesis in the non-implanted site in the endometrium is preserved as it is before implantation (Ishihara 1986b , Kinoshita 1986 ). Blastocyst implantation thus seems likely to affect the structure and function of the endometrium in its preparation of the optimal circumstances for in utero fetal development in mouse and rabbit.
On the other hand,,no one has yet clarified the details of the endometrial biochemical properties during implantation in humans. The human decidua obtained in early pregnancy, however, revealed the production of much less PGs than the endometrium obtained in the normal menstrual cycle by Abel et al. (1980) as well as by the present authors (Ishihara 1986a). These results prompted us to investigate the control mechanisms of PG production in human decidua to explain the change in PG synthesis in the endometrium in the nonpregnant uterus and the decidua in early pregnancy.
First of all, in our study, the difference in PG synthetase activities both of the decidua and endometrium was tested with microsomal fraction preparations from both tissues. The apparent Km and Vmax of the PG synthetase of the decidual microsome were virtually the same as those of the endometrial microsome. This implies that the inhibition of PG synthesis in the decidua seems unlikely to be caused by the difference between PG synthetase in the decidua and endometrium.
The cyclooxygenase activities of the decidua, amnion and placenta in the rabbit, however, during 20 to 30 days of pregnancy estimated with the oxygen uptake assay reported by Noden et al. (1981) were lower in the decidua than in the amnion and placenta.
It is thus possible to compare the change in PG synthetase activities in tissues other than the endometrium and the decidua, which is developed from the interstitial cells of the endometrium. Moreover, with regard to phospholipase A2 in humans, Bonny (1985) reported that the phospholipase A2 activity in the endometrium changed in phases of the menstrual cycle. Wilson et al. (1985) also found two phospholipase inhibiting proteins in human amniotic fluid of which the molecular weights were 150-160,000 and 70-80,000 daltons.
Thus phospholipase A2, one of the enzymes regulating PG production, might be involved in the process of low PG production in the decidua. In fact, Hoffman et al. (1984) demonstrated in the rabbit endometrium that the activity of phospholipase A2 was significantly greater in the implantation site than in non-implantation region. Despite the changes in phospholipase activities, however, the decrease in PG formation in the implantion site in the endo-metrium indicates the existence of a specific substance in the tissue which inhibits PG synthetase accompanied by normal activity.
As a matter of fact, Kinoshita et al. (1977) has reported obtaining a heat-unstable, nondialyzable inhibitor on PG synthetase in human decidual supernatant at the time of delivery. The inhibitory effect of 105,000g supernatant of the secretory phase of the endometrium and decidua in early pregnancy was thus investigated using seminal vesicle microsome. The results showed that the decidual supernatant contains PG synthetase inhibitor, of which the type of inhibition was competitive. On the other hand, the inhibitory effect of the endometrial supernatant was slight and non-specific as a result of kinetic analysis. Therefore, human decidua seems to possess a specific inhibitor of PG synthetase, differing from that of the endometrium.
In fact, inhibitory substances which regulate PG biosynthesis were found in human amniotic fluid and in amniotic cells (Wilson 1985) . These findings suggest that the endogenous inhibitor might play a significant role in PG production either in amnion or in decidua.
With regard to the inhibitor in the decidual supernatant, the experimental results imply that it is heat-unstable and that the inhibition of PG synthesis is not due to non-specific binding with the substrate.
In conclusion, it seems very likely that the decidua contains a specific inhibitor of PG biosynthesis which is involved in the regulation of PG biosynthesis in the decidua, resulting in a remarkable decrease in comparison with the endometrium. Purification of the inhibitor in the decidual supernatant is presently under study.
